BNP Paribas Exane Forecasts Strong Price Appreciation for Lam Research (NASDAQ:LRCX) Stock

Lam Research (NASDAQ:LRCX) had its target price boosted by investment analysts at BNP Paribas Exane from $250.00 to $260.00 in a report released on Thursday,MarketScreener reports. The brokerage presently has a “neutral” rating on the semiconductor company’s stock. BNP Paribas Exane’s price objective points to a potential downside of 1.81% from the stock’s current price.

Several other analysts have also recently commented on LRCX. Stifel Nicolaus lifted their price target on Lam Research from $300.00 to $325.00 and gave the company a “buy” rating in a report on Thursday. JPMorgan Chase & Co. raised their target price on shares of Lam Research from $165.00 to $300.00 and gave the stock an “overweight” rating in a research report on Thursday, January 29th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and set a $300.00 price target on shares of Lam Research in a research report on Wednesday, April 15th. UBS Group set a $300.00 price target on shares of Lam Research in a report on Thursday, January 29th. Finally, Citigroup restated a “buy” rating on shares of Lam Research in a report on Thursday. Twenty-seven research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and an average price target of $272.73.

Lam Research Stock Down 0.3%

LRCX opened at $264.79 on Thursday. The firm has a market cap of $330.67 billion, a P/E ratio of 54.26, a PEG ratio of 2.75 and a beta of 1.78. The business’s fifty day simple moving average is $233.80 and its 200 day simple moving average is $196.58. Lam Research has a 52 week low of $67.55 and a 52 week high of $273.50. The company has a quick ratio of 1.61, a current ratio of 2.26 and a debt-to-equity ratio of 0.37.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.11. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. The business had revenue of $5.84 billion during the quarter, compared to the consensus estimate of $5.70 billion. During the same period in the previous year, the firm posted $1.04 earnings per share. The company’s quarterly revenue was up 23.8% compared to the same quarter last year. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. As a group, equities research analysts anticipate that Lam Research will post 5.3 EPS for the current fiscal year.

Insider Activity at Lam Research

In other Lam Research news, insider Ava Harter sold 4,000 shares of the business’s stock in a transaction dated Monday, March 2nd. The stock was sold at an average price of $232.50, for a total transaction of $930,000.00. Following the transaction, the insider owned 54,705 shares in the company, valued at $12,718,912.50. The trade was a 6.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Eric Brandt sold 35,000 shares of the company’s stock in a transaction dated Friday, February 6th. The stock was sold at an average price of $225.60, for a total value of $7,896,000.00. Following the completion of the sale, the director directly owned 253,705 shares of the company’s stock, valued at $57,235,848. The trade was a 12.12% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 130,886 shares of company stock worth $29,658,802. 0.31% of the stock is currently owned by corporate insiders.

Institutional Trading of Lam Research

A number of hedge funds have recently made changes to their positions in the company. Norges Bank acquired a new stake in Lam Research during the 4th quarter valued at $3,645,427,000. Price T Rowe Associates Inc. MD boosted its position in Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company’s stock valued at $2,344,347,000 after buying an additional 10,666,540 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in shares of Lam Research by 781.3% during the third quarter. Arrowstreet Capital Limited Partnership now owns 11,340,865 shares of the semiconductor company’s stock valued at $1,518,542,000 after acquiring an additional 10,053,978 shares in the last quarter. Franklin Resources Inc. increased its position in shares of Lam Research by 57.0% during the fourth quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company’s stock worth $1,730,724,000 after acquiring an additional 3,671,073 shares during the last quarter. Finally, Corient Private Wealth LLC lifted its stake in shares of Lam Research by 235.5% in the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company’s stock worth $890,040,000 after acquiring an additional 3,649,553 shares in the last quarter. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Key Headlines Impacting Lam Research

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Lam reported fiscal Q3 results above estimates — $1.47 non-GAAP EPS vs. $1.36 consensus and $5.84B revenue (up 23.8% YoY). The release highlights record revenue and improved margins that underpinned the rally. PR Newswire
• Positive Sentiment: Management raised FYQ4 guidance: EPS $1.50–1.80 and revenue guidance midpoint (~$6.6B) came in above street expectations, signaling continued WFE strength. That upside to guidance is a primary driver of the rally. MarketBeat — Earnings
• Positive Sentiment: AI-driven chip demand is cited repeatedly as the demand engine — analysts and press note expanding spending on AI logic and memory fabs is lifting orders and margins for Lam’s etch/dep tools. Globe and Mail — Deep Dive
• Positive Sentiment: Wall Street raised targets and reiterated buys after the beat — examples include Needham ($300), BofA ($330) and TD Cowen ($340) — adding momentum as analysts push valuation higher. TipRanks — Ratings
• Neutral Sentiment: The company’s earnings call transcript and slide deck are available for investors digging into product-level demand, backlog and capex cadence. Seeking Alpha — Call Transcript
• Neutral Sentiment: Lam is named as a supplier for large-scale projects (e.g., Tesla Terafab), which supports long-duration revenue potential but requires execution and timelines to play out. Barchart — Terafab
• Negative Sentiment: Some commentators warn LRCX faces an earnings “test” after a sharp pre-report rally; elevated valuation metrics (P/E >50) mean expectations are high and leave limited room for disappointment. Seeking Alpha — Caution

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.